Kegg Pathway: Focal adhesion

KEGG ID: 04510

Reference Diagram

KEGG Diagram for Focal adhesion

Rat

There are 172 IPI Records from this pathway found in Rattus norvegicus.

Location of Focal adhesion proteins on Rat Genome

IPI Record Position
1: Actb 12:12047070-12050051
2: Actg1 10:109773489-109777655
3: Actn1 6:103110009-103282917
4: Actn2_predicted 17:68670924-68773261
5: Actn3 1:207475569-207492267
6: Actn4 1:84000723-84073767
7: Akt1 6:137640482-137657552
8: Akt2 1:82686233-82726544
9: Akt3 13:92807672-92924984
10: Arhgap5 6:72685228-72732787
11: Bad 1:209617373-209626292
12: Bcar1 19:41646190-41669265
13: Bcl2 13:12730736-12905108
14: Birc2 8:4649559-4668104
15: Birc3 8:4682202-4692389
16: Birc4 X:3011520-3055048
17: Braf 4:67121585-67243058
18: Capn2 13:98476339-98524037
19: Cav 4:42956107-42989054
20: Cav2 4:42932127-42939516
21: Cav3 4:148294428-148310380
22: Ccnd1 1:205360031-205366632
23: Ccnd2 4:163523817-163546501
24: Ccnd3 :-
25: Cdc42 5:156106131-156143040
26: Cep152_predicted 3:112864360-112933661
27: Chad 10:83201982-83205755
28: Col1a2 4:29393645-29428572
29: Col2a1 7:136679219-136707989
30: Col3a1 9:44281582-44317833
31: Col4a1 16:83045254-83157826
32: Col4a2_predicted 16:82885583-82951380
33: Col5a1 3:6826167-6971556
34: Col5a2 9:44375274-44440335
35: Col5a3 8:19789061-19834241
36: Col6a2 20:12444920-12464512
37: Col6a3_predicted 9:89965026-90027517
38: Comp :-
39: Crk 10:63017662-63040420
40: Crkl 11:85520244-85554667
41: Ctnnb1 8:125978161-125987670
42: Diap1_predicted 18:30757721-30855455
43: Egf 2:227107576-227194674
44: Egfr 14:97617358-97788213
45: Erbb2 10:87219085-87242919
46: Farp2_predicted 9:92807930-92907102
47: Figf X:50829626-50864445
48: Flna_predicted X:160359134-160385621
49: Flnb_predicted 15:18950018-19108490
50: Flnc_predicted 4:56313885-56340721
51: Flt1 12:7858092-8035966
52: Fn1 9:70702181-70771155
53: Fyn 20:43501853-43695567
54: Grb2 10:105722014-105818649
55: Grlf1_predicted 1:76757367-76824155
56: Gsk3b 11:64284731-64428698
57: Hgf 4:14864357-14932513
58: Hras 1:201385708-201388983
59: Ibsp 14:6548545-6561169
60: Igf1 7:24531690-24604843
61: Igf1r 1:122704987-122989472
62: Ilk 1:163481299-163487550
63: IPI00362823 3:61919851-62097221
64: IPI00371093 10:91557256-91574194
65: IPI00765011 :-
66: Itga1 2:47107864-47206261
67: Itga10_predicted 2:191448640-191466650
68: Itga11_predicted 8:66827530-66937187
69: Itga2 2:46967695-47040057
70: Itga3_predicted 10:83729230-83760455
71: Itga5 7:142254253-142277433
72: Itga6 3:54203293-54272888
73: Itga7 7:2230747-2269406
74: Itgav_predicted 3:66952418-67029317
75: Itgb1 19:58601188-58628500
76: Itgb3 :-
77: Itgb4 10:106080448-106116634
78: Itgb6 3:42286140-42360793
79: Itgb7 7:140971311-140984091
80: Jun 5:115359397-115360401
81: Kdr :-
82: Lama1_predicted 9:106855755-106980334
83: Lama2_predicted 1:18324869-18885248
84: Lama5 3:169234062-169282469
85: Lamb1_predicted 6:49115795-49182946
86: Lamb2 :-
87: Lamb3 13:109150531-109189940
88: Map2k1 8:68379077-68451583
89: Mapk1 11:85968732-86030389
90: Mapk10 14:7865731-8010694
91: Mapk3 1:185935044-185941249
92: Mapk8 16:8925133-8954535
93: Mapk9 10:35344672-35384319
94: Met 4:43134183-43211357
95: Myl2 12:35653817-35663865
96: Myl7_predicted 14:86568143-86570932
97: Myl9_predicted 3:147177777-147193863
98: Mylk2 3:143252234-143262989
99: Mylk_predicted 11:67604357-67782117
100: Mylpf 1:186472955-186474466
101: Pak1 1:155057622-155174714
102: Pak2 11:70529961-70588515
103: Pak3 X:34734814-34842093
104: Pak4_predicted 1:83671618-83718945
105: Pak6_predicted 3:105184040-105192149
106: Pak7_predicted 3:124152031-124457583
107: Parva 1:170232441-170387843
108: Parvb_predicted 7:122201280-122310356
109: Pdgfa 12:16155455-16172304
110: Pdgfb 7:118245297-118261626
111: Pdgfc 2:172635732-172811004
112: Pdgfd 8:3125622-3341187
113: Pdgfra 14:35369673-35418129
114: Pdgfrb 18:57014475-57053583
115: Pdpk1 10:13329849-13362023
116: Pgf 6:109218054-109225818
117: Pik3ca 2:118640277-118670170
118: Pik3cb 8:103886682-103957112
119: Pik3cd_predicted 5:166735338-166750186
120: Pik3cg_predicted 6:50444793-50477111
121: Pik3r1 2:32602673-32675350
122: Pik3r2 16:19171101-19179650
123: Pik3r3 5:136497494-136566473
124: Pip5k1b 1:227699696-227846963
125: Ppp1ca 1:206774701-206778330
126: Ppp1cb 6:24067538-24099280
127: Ppp1cc 12:35580169-35598339
128: Ppp1r12a 7:46876642-46985742
129: Prkca 10:97361597-97625118
130: Prkcb1 1:181118102-181459480
131: Prkcc 1:64145733-64172745
132: Pten 1:236771027-236837261
133: Ptk2 7:110933285-111084554
134: Pxn 12:42323997-42333765
135: Rac1 12:11380314-11400531
136: Rac2 7:116520066-116532482
137: Raf1 4:151752583-151775613
138: Rap1a 2:200980324-201058208
139: Rap1b 7:57132750-57139811
140: Rapgef1_v2 3:8634764-8673870
141: Reln 4:8150740-8609141
142: RGD1560062_predicted 20:43078138-43260577
143: RGD1563261_predicted 10:55182226-55247889
144: RGD1563276_predicted 11:68642354-68758943
145: RGD1564060_predicted 8:111016358-111030762
146: RGD1564327_predicted 17:86429719-86673201
147: RGD1565416_predicted 8:71532633-71717313
148: RGD1565941_predicted 2:204981254-205324562
149: RGD1565978_predicted 9:110171418-110186247
150: Rhoa :-
151: Rock1 18:1366989-1511865
152: Rock2 6:40581295-40667231
153: Shc1 2:181616581-181626968
154: Shc2_predicted 7:11583524-11604162
155: Shc3 17:19520647-19649496
156: Sos1 6:3310823-3394313
157: Sos2 6:91610826-91722481
158: Spp1 :-
159: Src 3:148157256-148170524
160: Thbs2 1:53587568-53611041
161: Thbs4 2:23010974-23065098
162: Tnn_predicted 13:75502882-75570228
163: Tnr 13:75271274-75344958
164: Vasp_predicted 1:78621488-78636917
165: Vav1 :-
166: Vav2_predicted 3:6155687-6347206
167: Vcl_predicted 15:3480195-3654131
168: Vegfa 9:10521733-10534238
169: Vegfb 1:209657632-209665750
170: Vegfc 16:40624417-40739692
171: Vtn 10:64609321-64612241
172: Vwf 4:161669202-161854761

Mouse

There are 172 IPI Records from this pathway found in Mus musculus.

Location of Focal adhesion proteins on Mouse Genome

IPI Record Position
1: Actb 5:143168256-143171864
2: Actg1 11:120161781-120164582
3: Actn1 12:81086385-81179156
4: Actn2 13:12323759-12395065
5: Actn3 19:4861223-4877884
6: Actn4 7:28602011-28671040
7: Akt1 :-
8: Akt2 7:27300516-27348213
9: Akt3 1:178862039-178967772
10: Arhgap5 12:53437868-53490452
11: Bad 19:7008905-7018937
12: Bcar1 8:114597147-114608054
13: Birc2 9:7818749-7835790
14: Birc3 9:7849220-7873545
15: Birc4 X:38315952-38350134
16: Braf 6:39543731-39654902
17: Capn2 1:184306854-184354029
18: Cav1 6:17256370-17291324
19: Cav2 6:17231310-17239004
20: Cav3 6:112425278-112438649
21: Ccnd1 7:144739321-144749220
22: Ccnd2 6:127091327-127116667
23: Ccnd3 17:46968322-47062874
24: Cdc42 4:136591778-136629755
25: Chad 11:94381157-94385217
26: Col11a1 3:114022623-114212291
27: Col11a2 17:33649891-33676696
28: Col1a1 11:94752360-94767959
29: Col1a2 6:4455840-4490729
30: Col2a1 15:97803005-97832691
31: Col3a1 1:45272979-45290601
32: Col4a1 8:11198403-11312702
33: Col4a2 8:11354249-11448288
34: Col4a4 1:82331582-82465816
35: Col4a6 X:136412396-136720444
36: Col5a1 2:27708694-27861166
37: Col5a2 1:45318877-45447828
38: Col5a3 9:20520452-20565436
39: Col6a1 10:76152508-76169760
40: Col6a2 10:76039478-76067043
41: Comp 8:73302547-73311055
42: Crk 11:75495505-75522289
43: Crkl 16:17365550-17399818
44: Ctnnb1 9:120782173-120809205
45: D830007F02Rik 8:88214406-88255279
46: Diap1 18:37969583-38061292
47: Dock1 7:134562672-135011989
48: Egf 3:129669600-129747338
49: Egfr 11:16652206-16813912
50: Elk1 X:20092248-20107547
51: Erbb2 11:98228574-98253806
52: Farp2 1:95358974-95452378
53: Figf X:159717653-159746755
54: Flna X:70476183-70499156
55: Flnb 14:6608561-6743464
56: Flnc 6:29383469-29411891
57: Flt1 5:147872545-148036360
58: Fn1 1:71518731-71586380
59: Fyn 10:39059219-39254797
60: Grb2 11:115460216-115524687
61: Gsk3b 16:38008240-38165318
62: Hgf 5:16065374-16131263
63: Hras1 7:141040427-141045314
64: Ibsp :-
65: Igf1 10:87288867-87361600
66: Igf1r 7:67826372-68100293
67: Ilk 7:105610473-105616745
68: IPI00462034 :-
69: Itga1 13:116080957-116222842
70: Itga10 3:96741908-96749918
71: Itga11 9:62475867-62581975
72: Itga2 13:115956703-116052930
73: Itga2b 11:102269387-102285973
74: Itga3 11:94860566-94892891
75: Itga4 2:79056339-79133962
76: Itga5 15:103172320-103194797
77: Itga6 2:71587779-71657597
78: Itga7 10:128336767-128361229
79: Itga8 2:12024513-12219773
80: Itga9 9:118455407-118747637
81: Itgav 2:83525354-83604646
82: Itgb1 8:131591503-131618179
83: Itgb3 11:104424146-104483465
84: Itgb4 11:115791069-115824502
85: Itgb5 16:33749412-33868892
86: Itgb6 2:60399131-60523442
87: Itgb7 15:102044030-102059969
88: Itgb8 12:119612103-119652710
89: Jun 4:94542255-94544189
90: Kdr 5:76214954-76260125
91: Lama1 17:67602232-67727594
92: Lama2 10:26670815-27306267
93: Lama3 18:12477560-12725832
94: Lama4 10:38654993-38799597
95: Lama5 2:180105782-180155210
96: Lamb1-1 12:31851443-31915700
97: Lamb2 9:108338048-108348632
98: Lamb3 1:195002750-195044602
99: Lamc1 1:154981138-155095004
100: Lamc2 1:154886248-154948205
101: Lamc3 2:31709290-31768544
102: Map2k1 9:63983787-64051430
103: Mapk1 16:16896945-16961016
104: Mapk10 5:103148770-103149081
105: Mapk3 7:126550780-126556964
106: Mapk8 14:32209888-32276220
107: Mapk9 11:49690177-49729834
108: Met 6:17441241-17521823
109: Myl2 5:122362366-122367386
110: Myl7 11:5796639-5798785
111: Mylc2b 17:70878820-70895373
112: Mylc2pl 5:136978805-136985721
113: Mylk 16:34735182-34920279
114: Mylk2 2:152608869-152614502
115: Mylpf 7:127004009-127005343
116: Pak1 7:97718145-97787562
117: Pak2 16:31937610-31999020
118: Pak3 X:138765079-139038221
119: Pak4 7:28267579-28277068
120: Pak6 2:118355211-118389459
121: Pak7 2:135773338-136079379
122: Parva 7:112218887-112382873
123: Parvb 15:84059809-84140797
124: Parvg 15:84152486-84170705
125: Pdgfa 5:139229656-139248584
126: Pdgfb 15:79823129-79842063
127: Pdgfc 3:81122343-81299958
128: Pdgfd 9:6168612-6377519
129: Pdgfra 5:75434033-75479895
130: Pdgfrb 18:61170519-61210428
131: Pdpk1 17:23803292-23869207
132: Pgf 12:86058457-86066066
133: Pik3ca 3:32627755-32654380
134: Pik3cb 9:98847754-98949439
135: Pik3cd 4:148492970-148542498
136: Pik3cg 12:32758720-32793858
137: Pik3r1 13:102781018-102868441
138: Pik3r2 8:73697168-73705691
139: Pik3r3 4:115719846-115800988
140: Pik3r5 11:68248320-68314041
141: Pip5k1c 10:80696188-80720532
142: Ppp1ca 19:4192157-4195419
143: Ppp1cb 5:32735733-32794014
144: Ppp1cc 7:119531075-119533375
145: Ppp1r12a 10:107566510-107681685
146: Prkca 11:107754338-108159844
147: Prkcb1 7:122080445-122419803
148: Prkcc :-
149: Pten 19:32823574-32892157
150: Ptk2 15:73032589-73250447
151: Pxn 5:115767727-115816985
152: Rac1 5:143761100-143783654
153: Rac2 15:78386424-78400038
154: Rac3 11:120537558-120540059
155: Raf1 6:115584217-115642173
156: Rap1a 3:105856338-105929392
157: Rap1b 10:117217464-117248907
158: Rapgef1 2:29441729-29562373
159: Reln 5:21397297-21856526
160: Rhoa 9:108164298-108196026
161: Rock1 18:10067465-10181315
162: Rock2 12:16920670-17003586
163: Shc1 3:89504541-89515942
164: Shc2 10:79022632-79040904
165: Shc3 13:51443539-51579580
166: Shc4 2:125318888-125415589
167: Sos1 17:80306507-80388261
168: Sos2 12:70502371-70576665
169: Spp1 5:104675436-104681350
170: Src 2:157115730-157163279
171: Thbs1 2:117804084-117815705
172: Thbs2 17:14405317-14428011
173: Thbs3 3:89301134-89312746
174: Thbs4 13:93852339-93895511
175: Tln1 4:43552618-43583522
176: Tnc 4:63446149-63533177
177: Tnn 1:161921713-161990219
178: Tnr 1:161574187-161761152
179: Tnxb 17:34278591-34327683
180: Vasp 7:18416239-18423349
181: Vav1 17:56964450-57013288
182: Vav2 2:27084113-27249042
183: Vav3 3:109468739-109813750
184: Vcl 14:19717950-19822228
185: Vegfa 17:45480574-45495331
186: Vegfb 19:7049516-7054647
187: Vegfc 8:55576304-55685794
188: Vtn 11:78315315-78318518
189: Vwf 6:125512595-125652158
190: Zyx 6:42279476-42289753

Human

There are 172 IPI Records from this pathway found in Homo sapiens.

Location of Focal adhesion proteins on Human Genome

IPI Record Position
1: ACTB 7:5533313-5535814
2: ACTN1 14:68410793-68515747
3: ACTN2 1:234916431-234994554
4: ACTN3 11:66070967-66087373
5: ACTN4 19:43830167-43913010
6: AKT1 14:104306734-104333125
7: AKT2 19:45430084-45483036
8: AKT3 1:241718158-242080053
9: ARHGAP5 14:31616246-31698685
10: BAD 11:63793878-63808740
11: BCAR1 16:73820430-73843004
12: BCL2 18:58941559-59137593
13: BIRC2 11:101723176-101754604
14: BIRC3 11:101693404-101713658
15: BIRC4 X:122821558-122875510
16: BRAF 7:140080754-140271033
17: CAPN2 1:221966657-222030343
18: CAV1 7:115952075-115988466
19: CAV2 7:115926680-115935830
20: CAV3 3:8750253-8763451
21: CCND1 11:69165054-69178422
22: CCND2 12:4253199-4284777
23: CCND3 6:42010649-42124404
24: CDC42 1:22235157-22292024
25: CHAD 17:45896860-45901322
26: COL11A1 1:103114611-103346640
27: COL11A2 6:33238447-33268254
28: COL1A1 17:45616456-45633992
29: COL1A2 7:93861809-93898480
30: COL2A1 12:46653018-46684528
31: COL3A1 2:189547344-189585717
32: COL4A1 13:109599311-109757505
33: COL4A2 13:109757632-109963375
34: COL4A4 2:227578177-227737519
35: COL4A6 X:107285493-107569383
36: COL5A1 9:136673473-136876507
37: COL5A2 2:189605486-189752733
38: COL5A3 19:9931237-9982147
39: COL6A1 21:46226111-46248443
40: COL6A2 21:46342470-46377189
41: COL6A3 2:237897401-237987559
42: COL6A6 3:131761902-131776061
43: COMP 19:18754584-18763114
44: CRK 17:1270733-1306302
45: CRKL 22:19601722-19638034
46: CTNNB1 3:41216004-41256938
47: DIAPH1 5:140875174-140978747
48: DOCK1 10:128584013-129140764
49: EGF 4:111053499-111152860
50: EGFR 7:55054219-55242524
51: ELK1 X:47379864-47394964
52: ERBB2 17:35104766-35138441
53: FARP2 2:241944384-242082928
54: FIGF X:15273640-15312498
55: FLNA X:153230088-153256188
56: FLNB 3:57969167-58133015
57: FLNC 7:128257719-128286568
58: FLT1 13:27773790-27967232
59: FN1 2:215933409-216009041
60: FYN 6:112088228-112301348
61: GRB2 17:70825753-70913384
62: GRLF1 19:52196889-52199655
63: GSK3B 3:121028238-121295954
64: HGF 7:81166258-81237388
65: HRAS 11:522243-525572
66: IBSP 4:88939757-88952098
67: IGF1 12:101313809-101398471
68: IGF1R 15:97010302-97319034
69: ILK 11:6581540-6588673
70: ITGA1 5:52119531-52285241
71: ITGA10 1:144236248-144255225
72: ITGA11 15:66381469-66511531
73: ITGA2 5:52321014-52423805
74: ITGA2B 17:39805076-39822399
75: ITGA3 17:45488431-45522843
76: ITGA4 2:182029864-182110711
77: ITGA5 12:53075316-53099317
78: ITGA6 2:173000616-173079256
79: ITGA7 12:54364640-54387949
80: ITGA8 10:15595954-15802130
81: ITGA9 3:37468817-37836285
82: ITGAV 2:187163045-187253872
83: ITGB1 10:33229326-33287204
84: ITGB3 17:42686207-42745076
85: ITGB4 17:71229111-71265493
86: ITGB5 3:125964488-126088842
87: ITGB6 2:160664438-160765009
88: ITGB7 12:51871375-51887267
89: ITGB8 7:20337271-20416944
90: JUN 1:59019048-59022587
91: KDR 4:55639401-55686519
92: LAMA1 18:6932078-7107813
93: LAMA2 6:129246035-129879407
94: LAMA3 18:19523560-19789025
95: LAMA4 6:112536654-112682605
96: LAMA5 20:60317510-60375763
97: LAMB1 7:107351499-107431040
98: LAMB2 3:49133663-49145603
99: LAMB3 1:207854843-207892443
100: LAMB4 7:107451232-107558036
101: LAMC1 1:181259176-181381350
102: LAMC2 1:181422022-181480662
103: LAMC3 9:132874325-132958267
104: LOC653852 :-
105: MAP2K1 15:64466674-64570935
106: MAPK1 22:20446873-20551730
107: MAPK10 4:87156656-87511051
108: MAPK3 16:30032951-30042116
109: MAPK8 10:49184739-49317409
110: MAPK9 5:179595388-179640218
111: MET 7:116099695-116223632
112: MLCK 16:45298960-45339722
113: MRCL3 18:3237528-3246226
114: MRLC2 18:3252123-3268247
115: MYL2 12:109833009-109842766
116: MYL5 4:657369-665816
117: MYL7 7:44144990-44147441
118: MYL8P :-
119: MYL9 20:34603311-34611640
120: MYLC2PL 7:101043475-101059118
121: MYLK 3:124813835-125085839
122: MYLK2 20:29870822-29886174
123: MYLPF 16:30293622-30296813
124: PAK1 11:76710709-76862581
125: PAK2 3:197951312-198043749
126: PAK3 X:110226244-110350815
127: PAK4 19:44308260-44361886
128: PAK6 15:38319361-38356979
129: PAK7 20:9466036-9767689
130: PARVA 11:12355679-12508914
131: PARVB 22:42726506-42896434
132: PARVG 22:42909088-42933741
133: PDGFA 7:504489-525557
134: PDGFB 22:37949310-37971006
135: PDGFC 4:157902214-158111996
136: PDGFD 11:103283131-103540317
137: PDGFRA 4:54790204-54859171
138: PDGFRB 5:149473598-149515615
139: PDPK1 16:2527971-2593189
140: PGF 14:74479162-74492220
141: PIK3CA 3:180349005-180435189
142: PIK3CB 3:139856921-139960875
143: PIK3CD 1:9634390-9711564
144: PIK3CG 7:106292977-106334801
145: PIK3R1 5:67547360-67633403
146: PIK3R2 19:18125016-18142343
147: PIK3R3 1:46278399-46371054
148: PIK3R5 17:8722953-8756559
149: PIP5K1C 19:3581182-3651445
150: PPP1CA 11:66922228-66925978
151: PPP1CB 2:28828118-28926981
152: PPP1CC 12:109642127-109665050
153: PPP1R12A 12:78692317-78853366
154: PRKCA 17:61729388-62237324
155: PRKCB1 16:23754823-24139358
156: PRKCG 19:59077279-59102713
157: PTEN 10:89612850-89721667
158: PTK2 8:141737683-142080514
159: PXN 12:119132637-119187904
160: RAC1 7:6380651-6410120
161: RAC2 22:35951238-35970241
162: RAC3 17:77582821-77585366
163: RAF1 3:12600108-12680678
164: RAP1A 1:111886363-112060836
165: RAP1B 12:67290919-67340641
166: RAPGEF1 9:133441978-133605282
167: RELN 7:102899473-103417199
168: RHOA 3:49371585-49424530
169: ROCK1 18:16787533-16944869
170: ROCK2 2:11239229-11402162
171: RP11-145H9.1 6:2608871-2696153
172: SHC1 1:153201398-153213476
173: SHC2 19:367593-411903
174: SHC3 9:90817880-90983502
175: SHC4 15:46903227-47042933
176: SOS1 2:39066469-39201067
177: SOS2 14:49654812-49767751
178: SPP1 4:89115890-89123592
179: SRC 20:35406502-35467239
180: THBS1 15:37660572-37676957
181: THBS2 6:169357800-169396064
182: THBS3 1:153432003-153444312
183: THBS4 5:79366859-79414866
184: TLN1 9:35687336-35722369
185: TLN2 15:60726802-60920733
186: TNC 9:116822634-116920260
187: TNN 1:173303617-173383825
188: TNR 1:173558558-173979529
189: TNXB 6:32161665-32191727
190: TTN 2:179099985-179380394
191: VASP 19:50702528-50722076
192: VAV1 19:6723722-6808371
193: VAV2 9:135616837-135847547
194: VAV3 1:107915305-108309108
195: VCL 10:75427878-75549924
196: VEGFA 6:43845924-43862202
197: VEGFB 11:63758646-63762834
198: VEGFC 4:177841685-177950889
199: VTN 17:23718425-23721844
200: VWF 12:5928308-6104097
201: ZYX 7:142788482-142798322

Google Scholar

Recent Literature

Integration of the beta-Catenin-Dependent Wnt Pathway with Integrin Signaling through the Adaptor Molecule Grb2.

PLoS One. 2009; 4(11): e7841
Crampton SP, Wu B, Park EJ, Kim JH, Solomon C, Waterman ML, Hughes CC

BACKGROUND: THE COMPLEXITY OF WNT SIGNALING LIKELY STEMS FROM TWO SOURCES: multiple pathways emanating from frizzled receptors in response to wnt binding, and modulation of those pathways and target gene responsiveness by context-dependent signals downstream of growth factor and matrix receptors. Both rac1 and c-jun have recently been implicated in wnt signaling, however their upstream activators have not been identified. METHODOLOGY/PRINCIPAL FINDINGS: Here we identify the adapter protein Grb2, which is itself an integrator of multiple signaling pathways, as a modifier of beta-catenin-dependent wnt signaling. Grb2 synergizes with wnt3A, constitutively active (CA) LRP6, Dvl2 or CA-beta-catenin to drive a LEF/TCF-responsive reporter, and dominant negative (DN) Grb2 or siRNA to Grb2 block wnt3A-mediated reporter activity. MMP9 is a target of beta-catenin-dependent wnt signaling, and an MMP9 promoter reporter is also responsive to signals downstream of Grb2. Both a jnk inhibitor and DN-c-jun block transcriptional activation downstream of Dvl2 and Grb2, as does DN-rac1. Integrin ligation by collagen also synergizes with wnt signaling as does overexpression of Focal adhesion Kinase (FAK), and this is blocked by DN-Grb2. CONCLUSIONS/SIGNIFICANCE: These data suggest that integrin ligation and FAK activation synergize with wnt signaling through a Grb2-rac-jnk-c-jun pathway, providing a context-dependent mechanism for modulation of wnt signaling.

Abnormalities in Focal adhesion Complex Formation, Regulation and Function in Human Autosomal Recessive Polycystic Kidney Disease (ARPKD) Epithelial Cells.

Am J Physiol Cell Physiol. 2009 Nov 18;
Israeli S, Amsler K, Zheleznova NN, Wilson PD

Integrin-associated Focal adhesion complex formation and turnover plays an essential role in directing interactions between epithelial cells and the extra-cellular matrix during organogenesis, leading to appropriate cell spreading, cell-matrix adhesion and migration. Autosomal Recessive Polycystic Kidney Disease (ARPKD) is associated with loss of function of PKHD1-encoded protein Fibrocystin-1 and is characterized by cystic dilation of renal collecting tubules (CT) in utero and loss of renal function in patients if they survive the perinatal period. Normal Polycystin1 (PC-1)/Focal adhesion complex function is required for control of CT diameter during renal development and abnormalities in these complexes have been demonstrated in human PC-1 mutant cystic cells. To determine whether loss of Fibrocystin-1 was associated with Focal adhesion abnormalities, ARPKD cells or normal age-matched (HF)CT cells in which Fibrocystin-1 had been decreased by 85% by siRNA inhibition were compared with normal HFCT. Accelerated attachment and spreading on collagen matrix and decreased motility of Fibrocystin-1-deficient cells was associated with longer paxillin-containing Focal adhesions, more complex actin-cystoskeletal rearrangements, and increased levels of total beta1-integrin, c-Src and paxillin. Immunoblot analysis of adhesive cells using site-specific phospho-antibodies demonstrated ARPKD-associated loss of activation of Focal adhesion kinase (FAK) by phosphorylation at its auto-phosphorylation site (Y397); accelerated FAK inhibition by phosphorylation at Y407, S843, and S910; as well as increased activation of c-Src at pY418. Paxillin co-immunoprecipitation analyses suggested that Fibrocystin-1 was a component of the normal Focal adhesion complex and that actin, and Fibrocystin-1 were lost from ARPKD complexes.

Identification of MYO18A as a Novel Interacting Partner of the PAK2/{beta}PIX/GIT1 Complex and Its Potential Function in Modulating Epithelial Cell Migration.

Mol Biol Cell. 2009 Nov 18;
Hsu RM, Tsai MH, Hsieh YJ, Lyu PC, Yu JS

Monitoring Editor: Jonathan Chernoff The p21-activated kinase (PAK) 2 is known to be involved in numerous biological functions, including the regulation of actin reorganization and cell motility. To better understand the mechanisms underlying this regulation, we herein used a proteomic approach to identify PAK2-interacting proteins in human epidermoid carcinoma A431 cells. We found that MYO18A, an emerging member of the myosin superfamily, is a novel PAK2 binding partner. Using a siRNA knockdown strategy and in vitro binding assay, we discovered that MYO18A binds to PAK2 through the betaPIX/GIT1 complex. Under normal conditions, MYO18A and PAK2 colocalized in lamellipodia and membrane ruffles. Interestingly, knockdown of MYO18A in cells did not prevent formation of the PAK2/betaPIX/GIT1 complex, but rather apparently changed its localization to Focal adhesions. Moreover, MYO18A-depleted cells showed dramatic changes in morphology, actin stress fiber and membrane ruffle formation, and displayed increases in the number and size of Focal adhesions. Migration assays revealed that MYO18A-depleted cells had decreased cell motility, and reexpression of MYO18A restored their migration ability. Collectively, our findings indicate that MYO18A is a novel binding partner of the PAK2/betaPIX/GIT1 complex, and suggest that MYO18A may play an important role in regulating epithelial cell migration via affecting multiple cell machineries.

Rab5 Mediates Caspase-8 Promoted Cell Motility and Metastasis.

Mol Biol Cell. 2009 Nov 18;
Torres VA, Mielgo A, Barbero S, Hsiao R, Wilkins JA, Stupack DG

Monitoring Editor: Joan Brugge Caspase-8 is a key apical sensory protein that governs cell responses to environmental cues, alternatively promoting apoptosis, proliferation and cell migration. The proteins responsible for integration of these pathways, however, have remained elusive. Here, we reveal that Rab5 regulates caspase-8-dependent signaling from integrins. Integrin ligation leads to Rab5 activation, association with integrins and activation of Rac, in a caspase-8 dependent manner. Rab5 activation promotes colocalization and coprecipitation of integrins with caspase-8, concomitant with Rab5 recruitment to integrin-rich regions such as Focal adhesions and membrane ruffles. Moreover, caspase-8 expression promotes Rab5 mediated internalization and the recycling of beta1 integrins, increasing cell migration independent of caspase catalytic activity. Conversely, Rab5 knockdown prevented caspase-8-mediated integrin signaling for Rac activation, cell migration, and apoptotic signaling, respectively. Similarly, Rab5 was critical for caspase-8-driven cell migration in vivo, since knockdown of Rab5 compromised the ability of caspase-8 to promote metastasis under nonapoptotic conditions. These studies identify Rab5 as a key integrator of caspase-8-mediated signal transduction downstream of integrins, regulating cell survival and migration in vivo and in vitro.

Rapamycin inhibits lung metastasis of B16 melanoma cells through down-regulating alphav integrin expression and up-regulating apoptosis signaling.

Cancer Sci. 2009 Oct 22;
Yang Z, Lei Z, Li B, Zhou Y, Zhang GM, Feng ZH, Zhang B, Shen GX, Huang B

Currently available data indicate the potential application of rapamycin and its analogues in the clinic as anticancer therapeutic agents through inhibiting tumor cell growth and tumor angiogenesis. However, whether rapamycin can directly suppress tumor metastasis remains unclear. In the present study, we demonstrated that rapamycin treatment results in reduced formation of metastatic nodules in the lung by B16 cells. This is due to two mechanisms. First, the expression of alphav integrin is down-regulated by rapamycin treatment, and subsequently, the phosphorylation of Focal adhesion kinase (FAK) is reduced. Second, rapamycin promotes apoptosis by up-regulating the proapoptotic molecules Bid and Bax and down-regulating Bcl-xL. Blocking the apoptosis pathway by pan-caspase inhibitor zVAD partially reversed the suppression of rapamycin in B16 metastasis. Interestingly, rapamycin up-regulates Bax and Bid in B16 cells via the S6K1 pathway and down-regulates the expression of alphav integrin via other pathway(s). In addition, our data showed that autophagy was not involved in the mechanisms of rapamycin-mediated metastasis suppression. Our findings demonstrate a potential anti-metastatic effect of rapamycin via down-regulating alphav integrin expression and up-regulating apoptosis signaling, suggesting that rapamycin might be worthy of clinical evaluation as an antimetastatic agent. (Cancer Sci 2009).

Phosphorylation of alpha-actinin-4 upon epidermal growth factor (EGF) exposure regulates its interaction with actin.

J Biol Chem. 2009 Nov 17;
Shao H, Wu C, Wells A

The ubiquitously expressed family of alpha-actinins bridges actin filaments to stabilize adhesions. During the dissolution of the actin cytoskeleton, actinins are phosphorylated on tyrosines, though the consequences of this are unknown. We expressed the two isoforms of human alpha-actinin in murine fibroblastand found that both alpha-actinin 1 (ACTN1) and alpha-actinin 4 (ACTN4) were phosphorylated on tyrosine residues after stimulation with epidermal growth factor (EGF), though ACTN4 was phosphorylated to the greater extent. This required the activation of Src protein tyrosine kinase and p38-MAPK but not MEK/ERK or Rac1. EGF-induced phosphorylation sites of ACTN4 were tyrosine 4, major, and tyrosine 31, minor. Truncation mutagenesis showed that the actin-binding head domains act as an inhibitory domain for both actin binding and EGF-mediated phosphorylation. Interestingly, a phospho-mimetic of tyrosine 265 (which is found in carcinoma cells, and lies near the K255E mutation that causes Focal segmental glomerulosclerosis) increased actin binding activity and susceptibility of ACTN4 to calpain-mediated cleavage; this variant retarded cell spreading. Remarkably, either treatment of cells with low concentrations of latrunculin A which has been shown to depolymerize F-actin or the deletion of the actin binding domain (ABD) (100-252aa) of ACTN4Y265E restored EGF-induced phosphorylation. An F-actin binding assay in vitro showed that Y4/31E, a mimetic of diphosphorylated ACTN4 bound F-actin slightly comparing to WT. Importantly, the EGF-mediated phosphorylation of ACTN4 at tyrosine 4 and 31 significantly inhibited multinucleation of proliferating NR6WT fibroblasts that overexpress ACTN4. These results suggest that EGF regulates the actin binding activity of ACTN4 by inducing tyrosyl-directed phosphorylation.

Gene Expression Profile of Fibrovascular Membranes from Patients with Proliferative Diabetic Retinopathy.

Br J Ophthalmol. 2009 Nov 16;
Yoshida S, Ogura A, Ishikawa K, Yoshida A, Kohno R, Yamaji Y, Ikeo K, Gojobori T, Kono T, Ishibashi T

BACKGROUND/AIMS: The purpose of this study was to generate a profile of genes expressed in preretinal fibrovascular membranes (FVMs) from patients with proliferative diabetic retinopathy. METHODS: A polymerase chain reaction (PCR)-amplified cDNA library was constructed using the RNAs isolated from FVMs obtained during vitrectomy. The sequence from the 5' end was obtained for randomly selected clones and used to generate expressed sequence tags (ESTs). Functional annotation was retrieved from Ensemble database and analyzed by FatiGo. The web-based VisANT software was used to identify the molecular networks within the FVMs. RESULTS: A total of 2816 ESTs were assembled in 625 nonredundant clusters. Among these, 515 matched the human cDNA database. The 515 clusters were subdivided by functional subsets of genes related to ribosomal activity, oxidative phosphorylation, Focal adhesion, cell adhesion, and other functions. Querying against VisANT database yielded 3175 possible physical relationships to other genes/proteins which included an additional 2480 genes that were not detected in the FVM library. CONCLUSIONS: The cDNA library constructed from human FVMs will be a valuable source of information that should facilitate a wide range of studies that can establish the molecular mechanisms underlying the development of FVMs.

Functional activation of proline-rich tyrosine kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

BMC Musculoskelet Disord. 2009 Nov 17; 10(1): 141
Wang M, Sun H, Zhang W, Zhang Y

ABSTRACT: BACKGROUND: Systemic lupus erythematosus (SLE) is a representative systemic autoimmune disease characterized by activated T cells and polyclonally activated B cells that produce autoantibodies. Activation of autoreactive T and B cells plays a pivotal role in the pathogenesis of this disease.A role of Focal adhesion kinase (FAK) in the pathogenesis has been suggested. Proline-rich tyrosine kinase2 (PYK2) is structurally related to FAK,however, the functional activation of PYK2 in SLE remains unclear. In the present study, we showed that PYK2 is significantly increased and activated in peripheral blood mononuclear cells (PBMCs) of patients with SLE. In addition, we showed the involvement of PYK2 proteins in the up-regulation of CD40L and CTLA4 expression and PBMC proliferation. METHOD: Freshly isolated PBMCs from 36 SLE patients, 19 patients with rheumatoid arthritis(RA) and 15 healthy individuals were analyzed for the expression and activation of PYK2 by western-blotting and immunocytochemistry. The other isolated PBMCs from patients with this condition were cultured and stimulated with PMA or TyrA9,and then the expression of costimulatory molecules CD40L and CTLA4 was evaluated using flow cytometry,PBMCs proliferation was determined with [3H]-thymidine incorporation (CPM). Result: Compared with RA patients and healthy donors,PBMCs from SLE patients expressed more of both the total PYK2 protein and its activated/phosphorylated form. The increase of activated PYK2 protein in SLE PBMCs was correlated with the complication of nephritis and inversly associated the level of serum complements. In active SLE patients, activation of PYK2 in PBMCs is accompanying the increased cell proliferation and the induced expression of costimulatory molecules CD40L and CTLA4. CONCLUSION: Our findings indicate that phosphorylated PYK2 in SLE PBMCs may induce the expression of CD40L and CTLA4, and subsequently the cell proliferation. PYK2 signaling enhances the autoreactive lymphocyte activation and plays an important role in the pathogenesis of SLE.

Hypoxia-inducible factor-1 alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

Breast Cancer Res. 2009 Nov 17; 11(6): R84
Kallergi G, Markomanolaki H, Giannoukaraki V, Papadaki MA, Strati A, Lianidou E, Georgoulias V, Mavroudis D, Agelaki S

ABSTRACT: INTRODUCTION: The detection of peripheral blood circulating tumor cells (CTCs) and bone marrow disseminated tumor cells (DTCs) in breast cancer patients is associated with a high incidence of disease relapse and disease-related death. Since hypoxia-inducible factor-1 alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF) play an important role in angiogenesis and tumor progression, the purpose of the current study was to investigate their expression in CTCs. METHODS: The expression of cytokeratins (CK), VEGF, vascular endothelial growth factor receptor-2 (VEGFR2), HIF-1 alpha and phosphorylated-Focal adhesion kinase (pFAK) in CTCs from 34 patients with metastatic breast cancer who had detectable CK-19 mRNA-positive CTCs was assessed using double staining experiments and conFocal laser scanning microscopy. Peripheral blood mononuclear cells (PBMCs) were stained with a monoclonal A45-B/B3 pancytokeratin antibody in combination with either VEGF or VEGFR2 or HIF-1 alpha or pFAK antibodies, respectively. RESULTS: pFAK expression in CTCs was detected in 92% of patients whereas expression of VEGF, VEGFR2 and HIF-1 alpha was observed in 62%, 47% and 76% of patients, respectively. VEGF, VEGFR2, HIF-1 alpha and pFAK were expressed in 73%, 71%, 56% and 81%, respectively, of all the detected CTCs. VEGF mRNA was also detected by quantitative real-time RT-PCR in immunomagnetically-separated CTCs. Double and triple staining experiments in cytospins of immunomagnetically-isolated CTCs showed that VEGF co-expressed with HIF-1 alpha and VEGFR2. CONCLUSIONS: The expression of pFAK, HIF-1 alpha, VEGF and VEGFR2 in CTCs of patients with metastatic breast cancer could explain the metastatic potential of these cells and may provide a therapeutic target for their elimination.

The G protein {beta}{gamma} subunit mediates reannealing of adherens junctions to reverse endothelial permeability increase by thrombin.

J Exp Med. 2009 Nov 16;
Knezevic N, Tauseef M, Thennes T, Mehta D

The inflammatory mediator thrombin proteolytically activates protease-activated receptor (PAR1) eliciting a transient, but reversible increase in vascular permeability. PAR1-induced dissociation of Galpha subunit from heterotrimeric Gq and G12/G13 proteins is known to signal the increase in endothelial permeability. However, the role of released Gbetagamma is unknown. We now show that impairment of Gbetagamma function does not affect the permeability increase induced by PAR1, but prevents reannealing of adherens junctions (AJ), thereby persistently elevating endothelial permeability. We observed that in the naive endothelium Gbeta1, the predominant Gbeta isoform is sequestered by receptor for activated C kinase 1 (RACK1). Thrombin induced dissociation of Gbeta1 from RACK1, resulting in Gbeta1 interaction with Fyn and Focal adhesion kinase (FAK) required for FAK activation. RACK1 depletion triggered Gbeta1 activation of FAK and endothelial barrier recovery, whereas Fyn knockdown interrupted with Gbeta1-induced barrier recovery indicating RACK1 negatively regulates Gbeta1-Fyn signaling. Activated FAK associated with AJ and stimulated AJ reassembly in a Fyn-dependent manner. Fyn deletion prevented FAK activation and augmented lung vascular permeability increase induced by PAR1 agonist. Rescuing FAK activation in fyn(-/-) mice attenuated the rise in lung vascular permeability. Our results demonstrate that Gbeta1-mediated Fyn activation integrates FAK with AJ, preventing persistent endothelial barrier leakiness.

Controlling the orientation and synaptic differentiation of myotubes with micropatterned substrates.

Biophys J. 2009 Nov 18; 97(10): 2771-9
Gingras J, Rioux RM, Cuvelier D, Geisse NA, Lichtman JW, Whitesides GM, Mahadevan L, Sanes JR

Micropatterned poly(dimethylsiloxane) substrates fabricated by soft lithography led to large-scale orientation of myoblasts in culture, thereby controlling the orientation of the myotubes they formed. Fusion occurred on many chemically identical surfaces in which varying structures were arranged in square or hexagonal lattices, but only a subset of patterned surfaces yielded aligned myotubes. Remarkably, on some substrates, large populations of myotubes oriented at a reproducible acute angle to the lattice of patterned features. A simple geometrical model predicts the angle and extent of orientation based on maximizing the contact area between the myoblasts and patterned topographic surfaces. Micropatterned substrates also provided short-range cues that influenced higher-order functions such as the localization of Focal adhesions and accumulation of postsynaptic acetylcholine receptors. Our results represent what we believe is a new approach for musculoskeletal tissue engineering, and our model sheds light on mechanisms of myotube alignment in vivo.

LIM domain-containing adaptor, leupaxin, localizes in Focal adhesion and suppresses the integrin-induced tyrosine phosphorylation of paxillin.

Cancer Sci. 2009 Oct 12;
Tanaka T, Moriwaki K, Murata S, Miyasaka M

Focal adhesion (FA) consists of multiple cellular proteins including paxillin and serves as a center for adhesion-mediated signaling. The assembly and disassembly of FAs is regulated by locally produced intracellular signals, and tyrosine phosphorylation of paxillin has been implicated in this process. A Lin-11 Isl-1 Mec-3 (LIM) domain-containing adaptor protein, leupaxin, a member of the paxillin family, is expressed in leukocytes as well as in certain cancer cells, and shares overall structural characteristics with paxillin. However, it remains unknown whether leupaxin and paxillin cooperate with or antagonize each other in integrin signaling. Here we show that leupaxin potently represses the tyrosine phosphorylation of paxillin. When expressed in mouse thymoma BW5147 cells bound to ICAM-1, leupaxin accumulated in FA-like patches in the cell periphery. When expressed in NIH3T3 and HEK293T cells, leupaxin localized to FAs upon cell adhesion to fibronectin and strongly suppressed the integrin-induced tyrosine phosphorylation of paxillin. In integrin-stimulated HEK293T cells, leupaxin's LIM3 domain appeared essential for selective FA localization and the suppression of paxillin tyrosine phosphorylation. Leupaxin's LD3 motif, which is critical for stable association with FAK, was dispensable for leupaxin's suppressive ability. In addition, leupaxin reduced the spreading of NIH3T3 cells on fibronectin, which required both the LD3 motif and LIM3 domain. When expressed in human leukocytic K562 cells, leupaxin significantly suppressed integrin alpha5beta1-mediated cell adhesion to fibronectin and the tyrosine phosphorylation of paxillin. These findings indicate that leupaxin functions as a paxillin counterpart that potently suppresses the tyrosine phosphorylation of paxillin during integrin signaling. (Cancer Sci 2009).

Focal adhesion Plaque Associated Cytoskeletons Are Involved in the Invasion and Metastasis of Human Colorectal Carcinoma.

Cancer Invest. 2009 Nov 16;
Yang HJ, Chen JZ, Zhang WL, Ding YQ

ABSTRACT The protein and mRNA expression of Focal adhesion plaque associated cytoskeletons, including talin, vinculin, paxillin, and tensin, was studied using immunofluorescence in combination with conFocal laser scanning microscopy and fluorescent quantitative polymerase chain reaction in 41 matched samples of human normal colorectal mucosae, primary colorectal adenocarcinomas, and 19 separate lymph node metastases. All specimens showed expression. The results showed talin, vinculin, tensin, and paxillin expression were correlated with carcinogenesis, invasion, and metastasis of colorectal carcinoma (CRC). Talin, vinculin, and tensin underwent downregulation while paxillin went up. So these cytoskeletons may play bidirectional regulating roles during the progression of CRC.

3,5,3',4',5'-Pentamethoxystilbene (MR-5), a Synthetically Methoxylated Analogue of Resveratrol, Inhibits Growth and Induces G1 Cell Cycle Arrest of Human Breast Carcinoma MCF-7 Cells.

J Agric Food Chem. 2009 Nov 16;
Pan MH, Lin CL, Tsai JH, Ho CT, Chen WJ

3,5,3',4',5'-Pentamethoxystilbene (MR-5) is a synthetically methoxylated analogue of resveratrol and has been suggested to have antitumor activity because of structural similarity to resveratrol. Herein, we investigate the antiproliferative effect of MR-5 in human breast cancer MCF-7 cells and demonstrate that MR-5 had a more potent inhibition on cell growth compared with resveratrol and other methoxylated derivatives. Exploring the growth-inhibitory mechanisms of MR-5, we found that it is accompanied by G1 cell cycle arrest, which coincides with a marked inhibition of G1 cell cycle regulatory proteins, including decreased cyclins (D1/D3/E) and cyclin-dependent kinases (CDK2/4/6) and increased CDK inhibitors (CKIs) such as p15, p16, p21, and p27. Furthermore, the increase in CKI levels by MR-5 resulted in a concomitant increase in their interactions of CDK4 and CDK2, along with a strong inhibition in CDK4 kinase activity and the accumulation of hypophosphorylated Rb. MR-5 also modulated some critical kinase activities related to cell cycle regulation, including Akt, mitogen-activated protein kinase (ERK1/2), p38 mitogen-activated protein kinase (p38 MAPK), and Focal adhesion kinase (FAK) in MCF-7 cells. In total, our results demonstrate that MR-5 affects multiple cellular targets that contribute to its antiproliferative activity in MCF-7 cells and provide novel information for synthetic chemists to design new antitumor agents with introduction of methoxylated group(s) in the basic compound.

Cerebral angiitis in four patients with chronic GVHD.

Bone Marrow Transplant. 2009 Nov 16;
Sostak P, Padovan CS, Eigenbrod S, Roeber S, Segerer S, Schankin C, Siegert S, Saam T, Theil D, Kolb HJ, Kretzschmar H, Straube A

There is growing evidence that GVHD affects the central nervous system (CNS). In this study, we describe the long-term follow-up of four allogeneic BM recipients who developed cerebral angiitis-like disease probably due to GVHD. The patients developed Focal neurological signs, cognitive deficits and/or coma in association with GVHD, 2-18 years after transplantation, following reduction of immunosuppressive therapy. Magnetic resonance imaging was variable, showing generalized brain atrophy, ischemic lesions or leukoencephalopathy. Diagnosis of cerebral angiitis was confirmed by histopathological analysis of bioptic brain tissue and response to immunosuppressive therapy. By means of immunohistochemistry and immunofluorescence, perivascular lymphomononuclear cerebral infiltrates were shown to express the adhesion receptor, CD11a, and the chemokine receptor, CCR5. Our findings imply that GVHD should be considered in the differential diagnosis of noninfectious angiitis-like disease of the CNS in long-term survivors after allogeneic BMT. Infiltrating cells, in analogy to typical target organs of GVHD such as skin or liver, expressed CD11a and CCR5. These findings could be of etiopathological, diagnostic and therapeutic relevance.Bone Marrow Transplantation advance online publication, 16 November 2009; doi:10.1038/bmt.2009.323.

Coronin 1C negatively regulates cell-matrix adhesion and motility of intestinal epithelial cells.

Biochem Biophys Res Commun. 2009 Nov 11;
Samarin S, Koch S, Ivanov A, Parkos C, Nusrat A

Coronins, WD-repeat actin-binding proteins, are known to regulate cell motility by coordinating actin filament turnover in lamellipodia of migrating cell. Here we report a novel mechanism of Coronin 1C-mediated cell motility that involves regulation of cell-matrix adhesion. RNAi silencing of Coronin 1C in intestinal epithelial cells enhanced cell migration and modulated lamellipodia dynamics by increasing the persistence of lamellipodial protrusion. Coronin 1C-depleted cells showed increased cell-matrix adhesions and enhanced cell spreading compared to control cells, while overexpression of Coronin 1C antagonized cell adhesion and spreading. Enhanced cell-matrix adhesion of coronin-deficient cells correlated with hyperphosphorylation of Focal adhesion Kinase (FAK) and paxillin, and an increase in number of Focal adhesions and their redistribution at the cell periphery. siRNA depletion of FAK in coronin-deficient cells rescued the effects of Coronin 1C depletion on motility, cell-matrix adhesion, and spreading. Thus, our findings provide the first evidence that Coronin 1C negatively regulates epithelial cell migration via FAK-mediated inhibition of cell-matrix adhesion.

Early activation of the beta-catenin pathway in osteocytes is mediated by nitric oxide, phosphatidyl inositol-3 kinase/akt, and Focal adhesion kinase.

Biochem Biophys Res Commun. 2009 Nov 11;
Santos A, Bakker AD, Zandieh-Doulabi B, de Blieck-Hogervorst JM, Klein-Nulend J

Bone mechanotransduction is vital for skeletal integrity. Osteocytes are thought to be the cellular structures that sense physical forces and transform these signals into a biological response. The Wnt/beta-catenin signaling pathway has been identified as one of the signaling pathways that is activated in response to mechanical loading, but the molecular events that lead to an activation of this pathway in osteocytes are not well understood. We assessed whether nitric oxide, Focal adhesion kinase, and/or the phosphatidyl inositol-3 kinase/Akt signaling pathway mediate loading-induced beta-catenin pathway activation in MLO-Y4 osteocytes. We found that mechanical stimulation by pulsating fluid flow (PFF, 0.7+/-0.3 Pa, 5 Hz) for 30 min induced beta-catenin stabilization and activation of the Wnt/beta-catenin signaling pathway. The PFF-induced stabilization of beta-catenin and activation of the beta-catenin signaling pathway was abolished by adding Focal kinase inhibitor FAK inhibitor-14 (50 muM), or phosphatidyl inositol-3 kinase inhibitor LY-294002 (50 muM). Addition of nitric oxide synthase inhibitor L-NAME (1.0 mM) also abolished PFF-induced stabilization of beta-catenin. This suggests that mechanical loading activates the beta-catenin signaling pathway by a mechanism involving nitric oxide, Focal adhesion kinase, and the Akt signaling pathway. These data provide a framework for understanding the role of beta-catenin in mechanical adaptation of bone.

[The influence of down-regulation of Focal adhesion kinase by RNA interference on the adhesion and migration of rat hepatic stellate cells in vitro]

Zhonghua Gan Zang Bing Za Zhi. 2009 Jul; 17(7): 509-14
An JY, Zhang XL, Yao DM, Dun ZN, Xie SR, Hao LS

OBJECTIVE: To investigate the role of Focal adhesion kinase (FAK) in adhesion and migration of hepatic stellate cells (HSC). METHODS: Two recombinant plasmids expressing short hairpin RNAs (shRNAs) targeting FAK were constructed and one plasmid substantially suppressing FAK expression in HSC was selected. Real-time PCR and Western blot were used to detect the knockdown effects of FAK gene. After 48-hour treatment with FAK shRNA, toluidine blue colorimetric assay was used to detect the cell adhesion. Wound-healing assay and improved Boyden double-chamber were used to detect the cell migration induced by FN. RESULTS: The recombinant plasmid expressing FAK shRNA was successfully constructed and transfected into HSC. Compared with the controls, the expression of FAK mRNA and protein in HSC treated with FAK shRNA was markedly down-regulated by 76.82% and 72.53%, respectively. The expression of p-FAK (Tyr397) protein was also decreased by 62.71% 48 h posttransfection. The adhesion of HSC was inhibited by 58.69% at 48 h after shRNA transfection. FAK gene silencing could also dramatically inhibit FN-stimulated HSC migration, and the cell migration distance and the cell number of crossing membrane were decreased by 58.27% and 83.70%, respectively. CONCLUSIONS: FAK gene silencing suppresses adhesion and migration of HSC, and FAK may be a potential target for novel anti-fibrosis therapies.

Suberoylanilide hydroxamic acid (SAHA) at subtoxic concentrations increases the adhesivity of human leukemic cells to fibronectin.

J Cell Biochem. 2009 Nov 12;
Kuželová K, Pluskalová M, Brodská B, Otevřelová P, Elknerová K, Grebeňová D, Hrkal Z

Suberoylanilide hydroxamic acid (SAHA) is an inhibitor of histone deacetylases (HDACs) which is being introduced into clinic for the treatment of hematological diseases. We studied the effect of this compound on six human hematopoietic cell lines (JURL-MK1, K562, CML-T1, Karpas-299, HL-60, and ML-2) as well as on normal human lymphocytes and on leukemic primary cells. SAHA induced dose-dependent and cell type-dependent cell death which displayed apoptotic features (caspase-3 activation and apoptotic DNA fragmentation) in most cell types including the normal lymphocytes. At subtoxic concentrations (0.5-1 microM), SAHA increased the cell adhesivity to fibronectin (FN) in all leukemia/lymphoma-derived cell lines but not in normal lymphocytes. This increase was accompanied by an enhanced expression of integrin beta1 and paxillin, an essential constituent of Focal adhesion complexes, both at the protein and mRNA level. On the other hand, the inhibition of ROCK protein, an important regulator of cytoskeleton structure, had no consistent effect on SAHA-induced increase in the cell adhesivity. The promotion of cell adhesivity to FN seems to be specific for SAHA as we observed no such effects with other HDAC inhibitors (trichostatin A and sodium butyrate). J. Cell. Biochem. (c) 2009 Wiley-Liss, Inc.

Role of Host Cell Polarity and Leading Edge Properties in Pseudomonas Type III Secretion.

Microbiology. 2009 Nov 12;
Bridge DR, Novotny MJ, Moore ER, Olson JC

Type III secretion (T3S) functions in establishing infections in a large number of Gram-negative bacteria, yet little is known about how host cell properties might function in this process. We used the opportunistic pathogen, Pseudomonas aeruginosa, and the ability to alter host cell sensitivity to Pseudomonas T3S to explore this problem. HT-29 epithelial cells were used to study cellular changes associated with loss of T3S sensitivity, which could be induced by treatment with methyl-beta-cyclodextrin or perfringolysin O. HL-60 promyelocytic cells are innately resistant to Pseudomonas T3S and were used to study cellular changes occurring in response to induction of T3S sensitivity, which occurred following treatment with phorbol esters. Using both cell models, a positive correlation was observed between eukaryotic cell adherence to tissue culture wells and T3S sensitivity. In examining the type of adhesion process linked to T3S sensitivity in HT-29 cells, a hierarchal order of protein involvement was identified that paralleled the architecture of leading edge Focal complexes. Conversely, in HL-60 cells induction of T3S sensitivity coincided with the onset of leading edge properties and the development of actin-rich projections associated with polarized cell migration. When leading edge architecture was examined by immunofluorescent staining for actin, Rac1, IQGAP1 and PI3 kinase, intact leading edge structure was found to closely correlate with host cell sensitivity to Pa-T3S. Our model for host cell involvement in Pseudomonas T3S proposes that cortical actin polymerization at the leading edge alters membrane properties to favor T3S translocon function and the establishment of infections, which is consistent with Pseudomonas infections targeting wounded epithelial barriers undergoing cell migration.